Embed Size (px)
Citation preview
Virology Education, P: +31302307140 F: +31302307148, E: [email protected]
www.virology-education.com
1- 3 June 2011, Milan Marriott Hotel, Milan, Italy
Again in 2011: Pre-workshop educational course for practicing clinicians
Virology Education, P: +31302307140 F: +31302307148, E: [email protected]
www.virology-education.com
David Back, MD, University of Liverpool, UK:Drug Drug Interactions
Marco Cavaleri, MD, EMA, London, UK:Regulatory issues with the clinical testing of the new HCV compounds
Marion Peters, MD, University of California, San Francisco, USAHIV/HBV coinfection in chronic kidney disease
Jürgen Rockstroh, MD, University of Bonn, Germany Acute HCV: overview ongoing cohort studies
Mark Sulkowski, MD, Johns Hopkins University, USAExpert’s overview of the latest data presented at the EASL
Kenneth Sherman, MD, PhD, University of Cincinnati College of Medicine, USAExpert’s overview of the latest data presented at the CROI
Stefan Zeuzem, MD, J.W. Goethe University Hospital, Frankfurt, GermanyNew DAA’s for Treatment of Hepatitis C: Promises and Challenges
CONFIRMED SPEAKERS
Virology Education, P: +31302307140 F: +31302307148, E: [email protected]
www.virology-education.com
REGISTRATION AND ABSTRACT SUBMISSION
Abstract topics:
- Immunology of HCV - Interactions between antiretrovirals and anti-HBV and anti-HCV agents- Treatment issues on HCV-HIV- Treatment issues on HBV-HIV - HCV resistance- HBV resistance- New anti-HCV drugs- Non invasive assessment of liver fibrosis- Liver steatosis- Liver toxicity- Liver cancer- Liver transplantation
- Delta Hepatitis
Deadline abstract submission: 1 April 2011
Registration timeline:
Early : 1 Feb. - 15 March 2011Regular : 16 March - 15 April 2011Late : 16 April - 15 May 2011 On-Site : 1, 2 and 3 June 2011
